Promising Growth Stocks To Consider - September 29th

Key Points

• Seven growth stocks including Canopy Growth, Prologis, and Teledyne Technologies, are highlighted as attractive investment options due to their high dollar trading volumes and potential for revenue growth.
• Growth stocks** are characterized by their focus on capital appreciation, typically reinvesting profits into expansion and development rather than paying dividends, which adds to their volatility and risk.
• Canopy Growth specializes in cannabis and hemp-based products for medical and recreational purposes, operating in multiple countries, while Prologis leads in logistics real estate with a focus on high-growth markets.

Canopy Growth, Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Trinity Capital, and Acadia Realty Trust are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose revenues and earnings are expected to grow at a faster-than-average rate compared to the broader market. Investors buy them primarily for capital appreciation, since these firms typically reinvest profits into expansion, research and development, or acquisitions rather than paying dividends. Because their value hinges on future growth projections, growth stocks can be more volatile and carry higher risk. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Read Our Latest Research Report on CGC

Prologis (PLD)

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.

Read Our Latest Research Report on PLD

Teledyne Technologies (TDY)

Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.

Read Our Latest Research Report on TDY

Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

Read Our Latest Research Report on ASND

Hamilton Lane (HLNE)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Read Our Latest Research Report on HLNE

Trinity Capital (TRIN)

Read Our Latest Research Report on TRIN

Acadia Realty Trust (AKR)

Read Our Latest Research Report on AKR